Literature DB >> 28603908

Depression profile in cancer patients and patients without a chronic somatic disease.

Christoph Nikendei1, Valentin Terhoeven1, Johannes C Ehrenthal1,2, Imad Maatouk1, Beate Wild1, Wolfgang Herzog1, Hans-Christoph Friederich1,3.   

Abstract

BACKGROUND: To investigate whether depressed oncology patients show a specific depressive symptom profile, we compared depression symptoms in depressed cancer patients (CANCER-DEP) and depressed patients without a chronic somatic disease (NONCANCER-DEP).
METHODS: Of a total of 2493 outpatients from a comprehensive cancer center and a center for psychosocial medicine, 1054 (42.3%) met the DSM-5 criteria for depression, measured with the Patient Health Questionnaire 9. Based on the Patient Health Questionnaire 9 scores, differences in severity of each of the 9 individual DSM-5 depression symptoms between CANCER-DEP (n = 542) and NONCANCER-DEP (n = 512) were examined. Non-depressed cancer patients (CANCER-NONDEP; n = 1216) served as a comparison group for somatic symptoms independent of depression in cancer. To control for depression severity, group comparisons were performed separately for patients with major depression and any depressive disorders.
RESULTS: Depressed cancer patients reported significantly lower levels of the cognitive-emotional depression symptoms "worthlessness" and "suicidal thoughts" than NONCANCER-DEP. Only 1 out of 5 somatic depression symptoms ("changes in appetite") was more pronounced in CANCER-DEP than in NONCANCER-DEP. Confirming previous research, somatic depression symptoms occurred more frequently in CANCER-DEP than in CANCER-NONDEP.
CONCLUSIONS: The lower level of cognitive-emotional symptoms in CANCER-DEP than in NONCANCER-DEP is discussed in relation to different psychosocial phenomena. Our results indicate that somatic depression symptoms are similarly pronounced in CANCER-DEP and NONCANCER-DEP, and that CANCER-DEP show greater somatic depression symptoms than CANCER-NONDEP. The presence of high levels of somatic symptoms should alert clinicians to investigate for a potential comorbid depression in cancer patients.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MDD; PHQ-9; cancer; cognitive-emotional symptoms; comorbidity; depression; metastasis; oncology; psychosocial; somatic symptoms

Mesh:

Year:  2017        PMID: 28603908     DOI: 10.1002/pon.4465

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  8 in total

1.  Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer.

Authors:  Zekai Shu; Baiqiang Dong; Lei Shi; Wei Shen; Qingqing Hang; Jin Wang; Yuanyuan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-24       Impact factor: 4.553

2.  Trends in incidence and associated risk factors of suicide mortality in patients with non-small cell lung cancer.

Authors:  Huaqiang Zhou; Wei Xian; Yaxiong Zhang; Gang Chen; Shen Zhao; Xi Chen; Zhonghan Zhang; Jiayi Shen; Shaodong Hong; Yan Huang; Li Zhang
Journal:  Cancer Med       Date:  2018-07-03       Impact factor: 4.452

3.  Food Insecurity Is Associated with Mental-Physical Comorbidities among U.S. Adults: NHANES 2013 to 2016.

Authors:  LaToya J O'Neal; Ara Jo; Lisa Scarton; Marino A Bruce
Journal:  Int J Environ Res Public Health       Date:  2022-02-01       Impact factor: 3.390

4.  Looking at individual symptoms: the dynamic network structure of depressive symptoms in cancer survivors and their preferences for psychological care.

Authors:  E A Bickel; M P J Schellekens; J G Smink; V E M Mul; A V Ranchor; J Fleer; M J Schroevers
Journal:  J Cancer Surviv       Date:  2022-08-17       Impact factor: 4.062

5.  Age-dependent associations among insomnia, depression, and inflammation in nurses.

Authors:  Jamie L Walker; Danica C Slavish; Megan Dolan; Jessica R Dietch; Sophie Wardle-Pinkston; Brett Messman; Camilo J Ruggero; Marian Kohut; Joshua Borwick; Kimberly Kelly; Daniel J Taylor
Journal:  Psychol Health       Date:  2020-08-14

6.  The value of distinct depressive symptoms (PHQ-9) to differentiate depression severity in cancer survivors: An item response approach.

Authors:  Loek J van der Donk; Esmée A Bickel; Wim P Krijnen; K Annika Tovote; Robbert Sanderman; Maya J Schroevers; Joke Fleer
Journal:  Psychooncology       Date:  2019-08-30       Impact factor: 3.894

7.  Depression profile in malignancy patients attending otorhinolaryngology clinic.

Authors:  Meera Niranjan Khadilkar; K Keshava Pai; Thripthi Rai; Vijendra Shenoy; Deviprasad Dosemane; Sushmitha Kabekkodu
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-17       Impact factor: 2.503

8.  Relationship between hepatocellular carcinoma and depression via online database analysis.

Authors:  Tiantian Han; Yingchun Zhou; Danhua Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.